Sundaram Mid Cap Fund
The scheme aims to achieve capital appreciation by investing in mid-cap stocks. The fund defines midcap as a stock whose market capitalization shall not exceed the market capitalization of the 50th stock (after sorting the securities in the descending order of market capitalization) listed with the NSE.
Growthvine rating: 3/5 — ranked #12 of 34 in category.
Fund basics
| Category | Equity: Mid Cap |
|---|
| NAV | ₹1474.90 (as of 2026-11-13) |
|---|
| AUM | ₹13,854 Cr |
|---|
| Expense ratio | 1.46% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Bharath S |
|---|
| Exit load | For units in excess of 25% of the investment, 1% will be charged for redemption within 365 days |
|---|
Performance & risk
| 5-year annualised return | 14.01% |
|---|
| Sharpe ratio | 0.58 |
|---|
| Standard deviation | 17.98% |
|---|
| Max drawdown | −68.66% |
|---|
| Alpha | 1.97 |
|---|
| Beta | 0.96 |
|---|
Over 5 years, captured 93.4% of NIFTY Midcap 150's upside and 86.6% of its downside.
Market cap allocation
| Large cap | 14.3% |
|---|
| Mid cap | 70.3% |
|---|
| Small cap | 15.3% |
|---|
Concentration
| Top 5 holdings | 12.1% |
|---|
| Top 10 holdings | 22.5% |
|---|
| Total holdings | 71 |
|---|
| Index overlap | 40.1% |
|---|
| Active share | 59.9% |
|---|
Top holdings
- TREPS — 3.7%
- Federal Bank Ltd. — 2.6%
- COFORGE LIMITED — 2.4%
- Thermax Ltd. — 2.4%
- Kalyan Jewellers India Limited — 2.4%
- Mahindra & Mahindra Financial Services Limited — 2.3%
- Sona BLW Precision Forgings Limited — 2.2%
- IDFC FIRST BANK LIMITED — 2.1%
- Mankind Pharma Limited — 2.1%
- The Phoenix Mills Ltd. — 2.0%
Top sectors
- Banking & Financial — 16.1%
- Retail — 7.3%
- Pharma & Biotech — 7.1%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 2.7% | Q3 | #24 of 31 |
| 2025 | 4.1% | Q2 | #10 of 29 |
| 2024 | 32.0% | Q2 | #9 of 29 |
| 2023 | 40.4% | Q2 | #9 of 28 |
| 2022 | 4.8% | Q2 | #8 of 22 |